These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15833886)

  • 21. Targeting the AIB1 oncogene through mammalian target of rapamycin inhibition in the mammary gland.
    Torres-Arzayus MI; Yuan J; DellaGatta JL; Lane H; Kung AL; Brown M
    Cancer Res; 2006 Dec; 66(23):11381-8. PubMed ID: 17145884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling.
    Zhang X; Mehta RG; Lantvit DD; Coschigano KT; Kopchick JJ; Green JE; Hedayat S; Christov KT; Ray VH; Unterman TG; Swanson SM
    Carcinogenesis; 2007 Jan; 28(1):143-50. PubMed ID: 16916863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development.
    Jerry DJ; Kittrell FS; Kuperwasser C; Laucirica R; Dickinson ES; Bonilla PJ; Butel JS; Medina D
    Oncogene; 2000 Feb; 19(8):1052-8. PubMed ID: 10713689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
    Chen J; Power KA; Mann J; Cheng A; Thompson LU
    Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen receptors ER alpha and ER beta in proliferation in the rodent mammary gland.
    Cheng G; Weihua Z; Warner M; Gustafsson JA
    Proc Natl Acad Sci U S A; 2004 Mar; 101(11):3739-46. PubMed ID: 14762170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Troglitazone enhances tamoxifen-induced growth inhibitory activity of MCF-7 cells.
    Yu HN; Noh EM; Lee YR; Roh SG; Song EK; Han MK; Lee YC; Shim IK; Lee SJ; Jung SH; Kim JS; Youn HJ
    Biochem Biophys Res Commun; 2008 Dec; 377(1):242-7. PubMed ID: 18835379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytoplasmic estrogen receptor in a pregnancy-dependent mouse mammary tumor (TPDMT-4) and related autonomous lines.
    Matsuzawa A; Mizuno Y; Yamamoto T; Hori T; Suzuki T
    Cancer Res; 1980 Sep; 40(9):3361-8. PubMed ID: 7427949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ.
    Namba R; Young LJ; Abbey CK; Kim L; Damonte P; Borowsky AD; Qi J; Tepper CG; MacLeod CL; Cardiff RD; Gregg JP
    Clin Cancer Res; 2006 Apr; 12(8):2613-21. PubMed ID: 16638874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats.
    Yuri T; Tsukamoto R; Uehara N; Matsuoka Y; Tsubura A
    In Vivo; 2006; 20(6B):829-36. PubMed ID: 17203775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential response of an ovarian-responsive mouse mammary tumor to androgenic and estrogenic agents.
    Matsuzawa A; Ikeda Y
    Cancer Res; 1983 Aug; 43(8):3680-6. PubMed ID: 6861137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway improves response of long-term estrogen-deprived breast cancer xenografts to antiestrogens.
    Sabnis G; Goloubeva O; Jelovac D; Schayowitz A; Brodie A
    Clin Cancer Res; 2007 May; 13(9):2751-7. PubMed ID: 17473209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P; Akram M; Benezra R; Brogi E
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LAS, a novel selective estrogen receptor modulator with chemopreventive and therapeutic activity in the N-nitroso-N-methylurea-induced rat mammary tumor model.
    Cohen LA; Pittman B; Wang CX; Aliaga C; Yu L; Moyer JD
    Cancer Res; 2001 Dec; 61(24):8683-8. PubMed ID: 11751385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous mammary intraepithelial lesions in dogs--a model of breast cancer.
    Antuofermo E; Miller MA; Pirino S; Xie J; Badve S; Mohammed SI
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2247-56. PubMed ID: 17982119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of estrogen receptor alpha transcriptional coregulators in tamoxifen resistance in breast cancer.
    Girault I; Bièche I; Lidereau R
    Maturitas; 2006 Jul; 54(4):342-51. PubMed ID: 16822624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Luteinizing hormone releasing hormone, estrogen, and progesterone receptors in canine mammary lesions and tumor cell lines.
    Sartin EA; Rahe CH; Wright JC; Sartin JL
    Anticancer Res; 1995; 15(5B):2029-32. PubMed ID: 8572597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term prophylactic tamoxifen reduces the incidence of antiestrogen-resistant/estrogen receptor-positive/progesterone receptor-negative mammary tumors.
    Rose-Hellekant TA; Skildum AJ; Zhdankin O; Greene AL; Regal RR; Kundel KD; Kundel DW
    Cancer Prev Res (Phila); 2009 May; 2(5):496-502. PubMed ID: 19401525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tamoxifen-resistant, ER-positive MAC 51 cell line with a high metastatic potential developed from a spontaneous breast cancer mouse model.
    Kumar JM; Kombairaju P; Nagarajan P; Subramanian T; Jose J; Ganapathy HS; Ohsugi T
    Cell Tissue Res; 2012 Nov; 350(2):347-60. PubMed ID: 22868912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis.
    Kuang SQ; Liao L; Wang S; Medina D; O'Malley BW; Xu J
    Cancer Res; 2005 Sep; 65(17):7993-8002. PubMed ID: 16140972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 28-amino-acid peptide fragment of the cupredoxin azurin prevents carcinogen-induced mouse mammary lesions.
    Mehta RR; Hawthorne M; Peng X; Shilkaitis A; Mehta RG; Beattie CW; Das Gupta TK
    Cancer Prev Res (Phila); 2010 Oct; 3(10):1351-60. PubMed ID: 20841487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.